LU86406A1 - Imidazoquinoleines antithrombogenes cardiotoniques - Google Patents

Imidazoquinoleines antithrombogenes cardiotoniques Download PDF

Info

Publication number
LU86406A1
LU86406A1 LU86406A LU86406A LU86406A1 LU 86406 A1 LU86406 A1 LU 86406A1 LU 86406 A LU86406 A LU 86406A LU 86406 A LU86406 A LU 86406A LU 86406 A1 LU86406 A1 LU 86406A1
Authority
LU
Luxembourg
Prior art keywords
imidazo
dihydro
formula
quinoline
compound according
Prior art date
Application number
LU86406A
Other languages
English (en)
French (fr)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU86406A1 publication Critical patent/LU86406A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LU86406A 1985-04-25 1986-04-24 Imidazoquinoleines antithrombogenes cardiotoniques LU86406A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72686985A 1985-04-25 1985-04-25
US72686985 1985-04-25
US83221286 1986-02-26
US06/832,212 US4668686A (en) 1985-04-25 1986-02-26 Imidazoquinoline antithrombrogenic cardiotonic agents

Publications (1)

Publication Number Publication Date
LU86406A1 true LU86406A1 (fr) 1986-11-05

Family

ID=27111398

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86406A LU86406A1 (fr) 1985-04-25 1986-04-24 Imidazoquinoleines antithrombogenes cardiotoniques

Country Status (32)

Country Link
US (1) US4668686A (sh)
KR (1) KR940000828B1 (sh)
CN (1) CN1016175B (sh)
AT (1) AT390257B (sh)
AU (1) AU592983B2 (sh)
BE (1) BE904671A (sh)
CA (1) CA1298836C (sh)
CH (1) CH675722A5 (sh)
CY (1) CY1641A (sh)
DE (1) DE3614132A1 (sh)
DK (3) DK164868C (sh)
EG (1) EG18104A (sh)
ES (3) ES8708229A1 (sh)
FI (1) FI83316C (sh)
FR (1) FR2581065B1 (sh)
GB (1) GB2174987B (sh)
GR (1) GR861086B (sh)
HK (1) HK64492A (sh)
HU (1) HU195813B (sh)
IL (1) IL78581A0 (sh)
IT (1) IT1215651B (sh)
LU (1) LU86406A1 (sh)
MY (1) MY102086A (sh)
NL (1) NL8601053A (sh)
NO (1) NO163406C (sh)
NZ (1) NZ215885A (sh)
OA (1) OA08242A (sh)
PT (1) PT82460B (sh)
SE (1) SE461468B (sh)
SG (1) SG29092G (sh)
SU (3) SU1450746A3 (sh)
YU (1) YU46054B (sh)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775674A (en) * 1986-05-23 1988-10-04 Bristol-Myers Company Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
US4701459A (en) * 1986-07-08 1987-10-20 Bristol-Myers Company 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
US4743607A (en) * 1987-05-29 1988-05-10 Merrell Dow Pharmaceuticals Inc. Cardiotonic tricyclic imidazolones
US4803210A (en) * 1987-05-29 1989-02-07 Merrell Dow Pharmaceuticals Inc. Cardiotonic tricyclic oxazolones
US4943573A (en) * 1989-11-01 1990-07-24 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
DE4035854C2 (de) * 1990-11-10 1996-10-02 Daimler Benz Ag Vorrichtung zum Fangen und Ableiten des von einem Fahrzeugrad hochgeschleuderten Spritzwassers
PH31245A (en) * 1991-10-30 1998-06-18 Janssen Pharmaceutica Nv 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
US5158958A (en) * 1992-04-03 1992-10-27 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl sulfonyl piperidine derivatives
US5348960A (en) * 1992-04-03 1994-09-20 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl tetrazolyl piperidine derivatives
US5196428A (en) * 1992-04-03 1993-03-23 Bristol-Myers Squibb Company Imidazo[4,5-b]qinolinyl oxy alkyl ureas
US5208237A (en) * 1992-04-03 1993-05-04 Bristol-Meyers Squibb Company 7-oxypropylsulfonamido-imidazo[4,5-b]quinolin-2-ones
US5552267A (en) * 1992-04-03 1996-09-03 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
JP2007502288A (ja) 2003-08-12 2007-02-08 スリーエム イノベイティブ プロパティズ カンパニー オキシム置換イミダゾ含有化合物
EP1658076B1 (en) 2003-08-27 2013-03-06 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
CA2537763A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
CA2540541C (en) 2003-10-03 2012-03-27 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
AU2004291101A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
AU2004291122A1 (en) * 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
JP4891088B2 (ja) 2003-11-25 2012-03-07 スリーエム イノベイティブ プロパティズ カンパニー 置換されたイミダゾ環系および方法
US8802853B2 (en) 2003-12-29 2014-08-12 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
US8735421B2 (en) 2003-12-30 2014-05-27 3M Innovative Properties Company Imidazoquinolinyl sulfonamides
WO2005094531A2 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
CA2592904C (en) 2004-12-30 2015-04-07 3M Innovative Properties Company Chiral fused [1,2]imidazo[4,5-c] ring compounds
WO2006083440A2 (en) 2004-12-30 2006-08-10 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
JP2008530113A (ja) 2005-02-11 2008-08-07 コーリー ファーマシューティカル グループ，インコーポレイテッド オキシムおよびヒドロキシラミン置換イミダゾ［４，５−ｃ］環化合物および方法
CA2602590A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
US7943610B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company Pyrazolopyridine-1,4-diamines and analogs thereof
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
US8227603B2 (en) 2006-08-01 2012-07-24 Cytokinetics, Inc. Modulating skeletal muscle
US8299248B2 (en) 2006-08-02 2012-10-30 Cytokinetics, Incorporated Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
HUE026571T2 (hu) 2006-08-02 2016-06-28 Cytokinetics Inc Adott kémiai anyagok, készítmények és imidazopiridineket magukba foglaló eljárások
EP2139478A4 (en) * 2007-03-30 2010-05-05 Cytokinetics Inc CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
AU2012281042B2 (en) 2011-07-13 2016-07-14 Cytokinetics, Inc. Combination ALS therapy
WO2024149378A1 (zh) * 2023-01-13 2024-07-18 上海超阳药业有限公司 喹啉酮化合物和萘啶酮化合物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones

Also Published As

Publication number Publication date
IL78581A0 (en) 1986-08-31
DK190986D0 (da) 1986-04-24
MY102086A (en) 1992-03-31
OA08242A (en) 1987-10-30
NZ215885A (en) 1989-04-26
HUT42089A (en) 1987-06-29
CN1016175B (zh) 1992-04-08
SG29092G (en) 1992-05-15
CA1298836C (en) 1992-04-14
SU1470192A3 (ru) 1989-03-30
ES557551A0 (es) 1988-02-16
FI83316B (fi) 1991-03-15
ES8708229A1 (es) 1987-10-01
AU592983B2 (en) 1990-02-01
YU46054B (sh) 1992-12-21
IT1215651B (it) 1990-02-22
PT82460A (en) 1986-05-01
SE461468B (sv) 1990-02-19
EG18104A (en) 1992-09-30
IT8620206A0 (it) 1986-04-24
DE3614132A1 (de) 1986-11-27
ES8801829A1 (es) 1988-02-16
DK165249C (da) 1993-03-22
SU1560056A3 (ru) 1990-04-23
AT390257B (de) 1990-04-10
FI861684A (fi) 1986-10-26
GB2174987B (en) 1989-08-02
FR2581065B1 (fr) 1990-02-02
DK165248B (da) 1992-10-26
DK164868C (da) 1993-01-11
CH675722A5 (sh) 1990-10-31
SE8601907L (sv) 1986-10-26
NO861617L (no) 1986-10-27
PT82460B (pt) 1988-11-30
GB8610037D0 (en) 1986-05-29
HU195813B (en) 1988-07-28
ES554336A0 (es) 1987-10-01
DK190986A (da) 1986-10-26
NO163406B (no) 1990-02-12
DK165249B (da) 1992-10-26
BE904671A (fr) 1986-10-24
SU1450746A3 (ru) 1989-01-07
DK80291D0 (da) 1991-04-30
CN86102747A (zh) 1987-02-04
FI861684A0 (fi) 1986-04-22
GB2174987A (en) 1986-11-19
DK80291A (da) 1991-04-30
ES557552A0 (es) 1988-07-16
ATA112186A (de) 1989-09-15
KR940000828B1 (ko) 1994-02-02
HK64492A (en) 1992-09-04
AU5641386A (en) 1986-10-30
DK164868B (da) 1992-08-31
KR860008177A (ko) 1986-11-12
GR861086B (en) 1986-09-01
SE8601907D0 (sv) 1986-04-24
FR2581065A1 (fr) 1986-10-31
ES8802521A1 (es) 1988-07-16
NO163406C (no) 1990-05-23
CY1641A (en) 1992-11-06
FI83316C (fi) 1991-06-25
NL8601053A (nl) 1986-11-17
YU116787A (en) 1988-04-30
DK165248C (da) 1993-03-22
DK81091A (da) 1991-05-01
DK81091D0 (da) 1991-05-01
US4668686A (en) 1987-05-26

Similar Documents

Publication Publication Date Title
LU86406A1 (fr) Imidazoquinoleines antithrombogenes cardiotoniques
US11001563B2 (en) SSAO inhibitor
EP0202164B1 (fr) Dérivés de (benzoyl-4 pipéridino)-2 phenyl-1 alcanols, leur préparation et leur application en thérapeutique
EP0031741A1 (fr) Nouveaux iminoacides substitués, leurs procédés de préparation et leur emploi comme inhibiteurs d'enzymes
EP0281459A1 (fr) Enantiomère dextrogyre de l'alpha-(tétrahydro-4,5,6,7 thiéno (3,2-c)pyridyl-5) (chloro-2 phényl)-acétate de méthyle, son procédé de préparation et les compositions pharmaceutiques le renfermant
PT1133474E (pt) Derivados da 4-arilquinolin-2-ona substituidos em 3 posições utilizados como moduladores do canal de potássio.
EP0611766A1 (fr) Dérivés de 2-amido-thiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament
JPH0471073B2 (sh)
EP0350403A1 (fr) Dérivés de (aza)naphtalènesultame, leurs procédés de préparation et les médicaments les contenant
JPH10511084A (ja) ポリアリールカルバモイルアザ及びカルバモイルアルカン二酸
IE870168L (en) Tetrahydrocarbazole derivatives.
US4134991A (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
FR2623808A1 (fr) Nouveaux derives flavonoides (benzyl-4 piperazinyl-1)-2 oxo-2 ethylene substitues, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
EP0431991B1 (fr) Nouveaux dérivés de benzonaphtyridine-1,8 leur préparation et les compositions qui les contiennent
CH650254A5 (fr) Quinolones, leurs procedes de preparation et compositions therapeutiques les contenant.
EP2953947A1 (fr) 3,5-diaryl-azaindoles comme inhibiteurs de la protéine dyrk1a pour le traitement des déficiences cognitives liées au syndrome de down et à la maladie d'alzheimer
WO1995019969A1 (fr) Derive de pyridazinone
FR2470132A1 (fr) 1-oxo-1h-thiazolo-(3,2-a)-pyrimidine-2-carboxamides, anti-allergiques et anti-ulcereux, medicament les contenant et composes intermediaires permettant de les obtenir
FR2543952A1 (fr) Composes hydrocarbones heterocycliques appartenant aux series indoliques et leur application pharmacologique
JPS6183179A (ja) 新規フラボン誘導体
EP0663903B1 (fr) Derives de dihydro-1,2 oxo-2 amino-3 quinoxalines, leur preparation et leur application en therapeutique
FR2599033A1 (fr) Derives des 3-(hydroxymethyl)-isoquinoleine, procede pour les preparer et compositions pharmaceutiques les contenant
EP0220104A2 (fr) Dérivés d'amino-5 pentanenitrile, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
JPS6284A (ja) イミダゾキノリン抗血栓性強心薬
JPH07101954A (ja) ベンズイミダゾール誘導体およびその用途